These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18626609)

  • 1. Noninvasive tracer techniques to characterize angiogenesis.
    Haubner R
    Handb Exp Pharmacol; 2008; (185 Pt 2):323-39. PubMed ID: 18626609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current insights on the biology and clinical aspects of VEGF regulation.
    Birk DM; Barbato J; Mureebe L; Chaer RA
    Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-based molecules in angiogenesis.
    D'Andrea LD; Del Gatto A; Pedone C; Benedetti E
    Chem Biol Drug Des; 2006 Feb; 67(2):115-26. PubMed ID: 16492159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor.
    Ferrara N
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):789-91. PubMed ID: 19164810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.
    Hall AP; Westwood FR; Wadsworth PF
    Toxicol Pathol; 2006; 34(2):131-47. PubMed ID: 16537292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppression through angiogenesis inhibition.
    Arsham AM; Simon MC
    Methods Mol Biol; 2003; 223():249-70. PubMed ID: 12777736
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemical approaches to angiogenesis.
    Chan J; Serluca FC
    Methods Cell Biol; 2004; 76():475-87. PubMed ID: 15602888
    [No Abstract]   [Full Text] [Related]  

  • 10. Imaging of integrin alphavbeta3 expression.
    Beer AJ; Schwaiger M
    Cancer Metastasis Rev; 2008 Dec; 27(4):631-44. PubMed ID: 18523730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors.
    Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY
    Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging of myocardial infarction.
    Jaffer FA; Sosnovik DE; Nahrendorf M; Weissleder R
    J Mol Cell Cardiol; 2006 Dec; 41(6):921-33. PubMed ID: 17067633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of angiogenesis in chronic lymphocytic leukemia.
    Letilovic T; Vrhovac R; Verstovsek S; Jaksic B; Ferrajoli A
    Cancer; 2006 Sep; 107(5):925-34. PubMed ID: 16832815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alphavbeta3 integrin and angiogenesis: a moody integrin in a changing environment.
    Hodivala-Dilke K
    Curr Opin Cell Biol; 2008 Oct; 20(5):514-9. PubMed ID: 18638550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of angiogenesis inhibitors in tumor diseases--preclinical data]].
    Berdel WE; Panse J
    Onkologie; 2005 Oct; 28 Suppl 4():25-8. PubMed ID: 16205102
    [No Abstract]   [Full Text] [Related]  

  • 16. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
    Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
    Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted in vivo imaging of angiogenesis: present status and perspectives.
    Choe YS; Lee KH
    Curr Pharm Des; 2007; 13(1):17-31. PubMed ID: 17266586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotracer-based strategies to image angiogenesis.
    Haubner RH; Wester HJ; Weber WA; Schwaiger M
    Q J Nucl Med; 2003 Sep; 47(3):189-99. PubMed ID: 12897710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenesis, anti-VEGF(R) and outlook.
    Petersen I
    Recent Results Cancer Res; 2007; 176():189-99. PubMed ID: 17607926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial distribution of VEGF isoforms and chemotactic signals in the vicinity of a tumor.
    Small AR; Neagu A; Amyot F; Sackett D; Chernomordik V; Gandjbakhche A
    J Theor Biol; 2008 Jun; 252(4):593-607. PubMed ID: 18395755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.